Eli Lilly and Co. CEO John Lechleiter told Wall Street analysts recently that, while there have been “individual huge drug price increases,” the overall cost of drugs is rising very slowly and remains a small part of overall U.S. health care spending.
Sandra is the daughter of Sidney and Lois Eskenazi, the couple who provided a $40 million gift to the Eskenazi Health Capital Campaign and for whom the Eskenazi Health system is named.
The Indiana State Department of Health sent letters to 305,000 parents who haven’t vaccinated their children for a virus known to cause cervical cancer. Conservative groups have objected to what they call an intrusion into parenting decisions.
Rx Help Centers assists employers and customers as they navigate through the confusing web of prescription drug discounts. Business is so good that the company hopes to add 250 workers by 2017.
The state agency said Tuesday there were 114 preventable adverse medical incidents in hospitals and health care facilities in 2014.
The Indianapolis-based hospital system announced the donation from John Schnatter Thursday during a groundbreaking ceremony for St. Vincent House, which will include private units for 20 families who have a child or loved receiving extended care.
Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
Eli Lilly and Co. beat Wall Street’s expectations with its third-quarter profit, prompting the drugmaker to raise its full-year forecast by as much as 20 cents per share.
Presidential candidate Hillary Rodham Clinton warned Wednesday that the planned $48B deal could stifle competition between health insurers, including in the early battleground state of New Hampshire.
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
The Indianapolis-based law firm opened two new offices this fall—in Dallas and Seattle—and has now added five new offices in the past 24 months, as it tries to keep up with consolidation among hospitals and doctors.
The federal penalty for having no health insurance is set to jump to $695, and the Obama administration is being urged to highlight that cold fact to help drive more sign-ups.
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Health and Human Services Secretary Sylvia M. Burwell set a target of 10 million people enrolled and paying their premiums by the end of next year—about half the enrollment that was originally predicted.
Gov. Mike Pence cited the successes of a $1 million pilot program as reason for granting a new $3.5 million contract to Real Alternatives, a Pennsylvania-based charity.
Long-time health care executive Charles C. Miraglia was picked by the center’s board of directors to replace interim CEO Dan A. Waxman, who has been in that position since January.
William S. Gibbons Jr., Cook's vice president of of global engineering, and his 15-year-old daughter, Abbey, were killed when the plane crashed into Buffalo Mountain in eastern Tennessee.
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
Spending on prescription drugs has soared 451 percent this year at Indianapolis-based MDwise as new drugs for hepatitis C and cancer soar above $100,000 per patient.
